Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to understand what the study involves and all important details about it
- People who are able to sign and provide written consent following the required guidelines
- People who have a confirmed diagnosis of invasive breast cancer, proven through laboratory testing of tissue or cell samples
- People with breast cancer at clinical stage 1, 2, or 3
- People whose cancer is considered suitable for surgical removal
- People whose breast cancer tumour tests show estrogen receptor positive results in more than 10% of cells, as documented by a laboratory or medical record
- People whose breast cancer tests as HER2 negative or HER2 low on their most recent tumour biopsy, as documented by a laboratory or medical record — and, if HER2 low, people who are not considered candidates for HER2-targeted treatment (confirm with trial site)
- People who are able to swallow and take oral (by mouth) medication
- People who are willing and able to attend scheduled visits, follow the treatment plan, and stay in contact with the research team
- People aged 21 years or older
Who may not be able to join:
- People who are unable to comply with taking neoadjuvant endocrine therapy (NET), which is hormone-based treatment given before surgery (confirm with trial site)
- People who are unable to follow the study procedures as required
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 202-741-2277
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Response to neoadjuvant endocrine therapy (NET)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.